O	0	8	Vascular	Vascular	JJ	B-NP
O	9	20	endothelial	endothelial	JJ	I-NP
O	21	27	growth	growth	NN	I-NP
O	28	34	factor	factor	NN	I-NP
O	35	36	(	(	(	O
O	36	40	VEGF	VEGF	NN	B-NP
O	40	41	)	)	)	O
O	42	44	in	in	IN	B-PP
O	45	53	seizures	seizure	NNS	B-NP
O	53	54	:	:	:	O
O	55	56	a	a	DT	B-NP
O	57	63	double	double	JJ	I-NP
O	63	64	-	-	HYPH	I-NP
O	64	69	edged	edged	JJ	I-NP
O	70	75	sword	sword	NN	I-NP
O	75	76	.	.	.	O

O	77	85	Vascular	Vascular	JJ	B-NP
O	86	97	endothelial	endothelial	JJ	I-NP
O	98	104	growth	growth	NN	I-NP
O	105	111	factor	factor	NN	I-NP
O	112	113	(	(	(	O
O	113	117	VEGF	VEGF	NN	B-NP
O	117	118	)	)	)	O
O	119	121	is	be	VBZ	B-VP
O	122	123	a	a	DT	B-NP
B-Multi-tissue_structure	124	132	vascular	vascular	JJ	I-NP
O	133	139	growth	growth	NN	I-NP
O	140	146	factor	factor	NN	I-NP
O	147	152	which	which	WDT	B-NP
O	153	160	induces	induce	VBZ	B-VP
O	161	173	angiogenesis	angiogenesis	NN	B-NP
O	174	175	(	(	(	O
O	175	178	the	the	DT	B-NP
O	179	190	development	development	NN	I-NP
O	191	193	of	of	IN	B-PP
O	194	197	new	new	JJ	B-NP
B-Multi-tissue_structure	198	203	blood	blood	NN	I-NP
I-Multi-tissue_structure	204	211	vessels	vessel	NNS	I-NP
O	211	212	)	)	)	O
O	212	213	,	,	,	O
B-Multi-tissue_structure	214	222	vascular	vascular	JJ	B-NP
O	223	235	permeability	permeability	NN	I-NP
O	235	236	,	,	,	O
O	237	240	and	and	CC	O
O	241	253	inflammation	inflammation	NN	B-NP
O	253	254	.	.	.	O

O	255	257	In	In	IN	B-PP
B-Organ	258	263	brain	brain	NN	B-NP
O	263	264	,	,	,	O
O	265	274	receptors	receptor	NNS	B-NP
O	275	278	for	for	IN	B-PP
O	279	283	VEGF	VEGF	NN	B-NP
O	284	288	have	have	VBP	B-VP
O	289	293	been	be	VBN	I-VP
O	294	303	localized	localized	JJ	B-ADJP
O	304	306	to	to	TO	B-PP
B-Tissue	307	315	vascular	vascular	JJ	B-NP
I-Tissue	316	327	endothelium	endothelium	NN	I-NP
O	327	328	,	,	,	O
B-Cell	329	336	neurons	neuron	NNS	B-NP
O	336	337	,	,	,	O
O	338	341	and	and	CC	O
B-Cell	342	346	glia	glia	NN	B-NP
O	346	347	.	.	.	O

O	348	352	VEGF	VEGF	NN	B-NP
O	353	355	is	be	VBZ	B-VP
O	356	367	upregulated	upregulate	VBN	I-VP
O	368	373	after	after	IN	B-PP
O	374	381	hypoxic	hypoxic	JJ	B-NP
O	382	388	injury	injury	NN	I-NP
O	389	391	to	to	TO	B-PP
O	392	395	the	the	DT	B-NP
B-Organ	396	401	brain	brain	NN	I-NP
O	401	402	,	,	,	O
O	403	408	which	which	WDT	B-NP
O	409	412	can	can	MD	B-VP
O	413	418	occur	occur	VB	I-VP
O	419	425	during	during	IN	B-PP
B-Organ	426	434	cerebral	cerebral	JJ	B-NP
O	435	443	ischemia	ischemia	NN	I-NP
O	444	446	or	or	CC	O
O	447	451	high	high	JJ	B-NP
O	451	452	-	-	HYPH	I-NP
O	452	460	altitude	altitude	NN	I-NP
B-Pathological_formation	461	466	edema	edema	NN	I-NP
O	466	467	,	,	,	O
O	468	471	and	and	CC	O
O	472	475	has	have	VBZ	B-VP
O	476	480	been	be	VBN	I-VP
O	481	491	implicated	implicate	VBN	I-VP
O	492	494	in	in	IN	B-PP
O	495	498	the	the	DT	B-NP
B-Multi-tissue_structure	499	504	blood	blood	NN	I-NP
I-Multi-tissue_structure	504	505	-	-	HYPH	I-NP
I-Multi-tissue_structure	505	510	brain	brain	NN	I-NP
I-Multi-tissue_structure	511	518	barrier	barrier	NN	I-NP
O	519	528	breakdown	breakdown	NN	I-NP
O	529	539	associated	associate	VBN	B-VP
O	540	544	with	with	IN	B-PP
O	545	550	these	these	DT	B-NP
O	551	561	conditions	condition	NNS	I-NP
O	561	562	.	.	.	O

O	563	568	Given	Give	VBN	B-PP
O	569	572	its	its	PRP$	B-NP
O	573	581	recently	recently	RB	I-NP
O	581	582	-	-	HYPH	I-NP
O	582	591	described	describe	VBN	I-NP
O	592	596	role	role	NN	I-NP
O	597	599	as	as	IN	B-PP
O	600	602	an	an	DT	B-NP
O	603	615	inflammatory	inflammatory	JJ	I-NP
O	616	624	mediator	mediator	NN	I-NP
O	624	625	,	,	,	O
O	626	630	VEGF	VEGF	NN	B-NP
O	631	636	could	could	MD	B-VP
O	637	641	also	also	RB	I-VP
O	642	652	contribute	contribute	VB	I-VP
O	653	655	to	to	TO	B-PP
O	656	659	the	the	DT	B-NP
O	660	672	inflammatory	inflammatory	JJ	I-NP
O	673	682	responses	response	NNS	I-NP
O	683	691	observed	observe	VBN	B-VP
O	692	694	in	in	IN	B-PP
B-Organ	695	703	cerebral	cerebral	JJ	B-NP
O	704	712	ischemia	ischemia	NN	I-NP
O	712	713	.	.	.	O

O	714	719	After	After	IN	B-PP
O	720	728	seizures	seizure	NNS	B-NP
O	728	729	,	,	,	O
B-Multi-tissue_structure	730	735	blood	blood	NN	B-NP
I-Multi-tissue_structure	735	736	-	-	HYPH	I-NP
I-Multi-tissue_structure	736	741	brain	brain	NN	I-NP
I-Multi-tissue_structure	742	749	barrier	barrier	NN	I-NP
O	750	759	breakdown	breakdown	NN	I-NP
O	760	763	and	and	CC	I-NP
O	764	776	inflammation	inflammation	NN	I-NP
O	777	779	is	be	VBZ	B-VP
O	780	784	also	also	RB	I-VP
O	785	793	observed	observe	VBN	I-VP
O	794	796	in	in	IN	B-PP
B-Organ	797	802	brain	brain	NN	B-NP
O	802	803	,	,	,	O
O	804	810	albeit	albeit	IN	B-ADVP
O	811	813	on	on	IN	B-PP
O	814	815	a	a	DT	B-NP
O	816	821	lower	low	JJR	I-NP
O	822	827	scale	scale	NN	I-NP
O	828	832	than	than	IN	B-PP
O	833	837	that	that	DT	B-NP
O	838	846	observed	observe	VBN	B-VP
O	847	852	after	after	IN	B-PP
O	853	859	stroke	stroke	NN	B-NP
O	859	860	.	.	.	O

O	861	867	Recent	Recent	JJ	B-NP
O	868	876	evidence	evidence	NN	I-NP
O	877	880	has	have	VBZ	B-VP
O	881	890	suggested	suggest	VBN	I-VP
O	891	892	a	a	DT	B-NP
O	893	897	role	role	NN	I-NP
O	898	901	for	for	IN	B-PP
O	902	914	inflammation	inflammation	NN	B-NP
O	915	917	in	in	IN	B-PP
O	918	925	seizure	seizure	NN	B-NP
O	926	935	disorders	disorder	NNS	I-NP
O	935	936	.	.	.	O

O	937	939	We	We	PRP	B-NP
O	940	944	have	have	VBP	B-VP
O	945	954	described	describe	VBN	I-VP
O	955	963	striking	striking	JJ	B-NP
O	964	973	increases	increase	NNS	I-NP
O	974	976	in	in	IN	B-PP
O	977	981	VEGF	VEGF	NN	B-NP
O	982	989	protein	protein	NN	I-NP
O	990	992	in	in	IN	B-PP
O	993	997	both	both	CC	O
B-Cell	998	1005	neurons	neuron	NNS	B-NP
O	1006	1009	and	and	CC	O
B-Cell	1010	1014	glia	glia	NN	B-NP
O	1015	1020	after	after	IN	B-PP
O	1021	1032	pilocarpine	pilocarpine	NN	B-NP
O	1032	1033	-	-	HYPH	B-NP
O	1033	1040	induced	induce	VBN	I-NP
O	1041	1047	status	status	NN	I-NP
O	1048	1059	epilepticus	epilepticus	NN	I-NP
O	1060	1062	in	in	IN	B-PP
O	1063	1066	the	the	DT	B-NP
B-Organ	1067	1072	brain	brain	NN	I-NP
O	1072	1073	.	.	.	O

O	1074	1083	Increases	Increase	NNS	B-NP
O	1084	1086	in	in	IN	B-PP
O	1087	1091	VEGF	VEGF	NN	B-NP
O	1092	1097	could	could	MD	B-VP
O	1098	1108	contribute	contribute	VB	I-VP
O	1109	1111	to	to	TO	B-PP
O	1112	1115	the	the	DT	B-NP
B-Multi-tissue_structure	1116	1121	blood	blood	NN	I-NP
I-Multi-tissue_structure	1121	1122	-	-	HYPH	I-NP
I-Multi-tissue_structure	1122	1127	brain	brain	NN	I-NP
I-Multi-tissue_structure	1128	1135	barrier	barrier	NN	I-NP
O	1136	1145	breakdown	breakdown	NN	I-NP
O	1146	1149	and	and	CC	I-NP
O	1150	1162	inflammation	inflammation	NN	I-NP
O	1163	1171	observed	observe	VBN	B-VP
O	1172	1177	after	after	IN	B-PP
O	1178	1186	seizures	seizure	NNS	B-NP
O	1186	1187	.	.	.	O

O	1188	1195	However	However	RB	B-ADVP
O	1195	1196	,	,	,	O
O	1197	1201	VEGF	VEGF	NN	B-NP
O	1202	1205	has	have	VBZ	B-VP
O	1206	1210	also	also	RB	I-VP
O	1211	1215	been	be	VBN	I-VP
O	1216	1221	shown	show	VBN	I-VP
O	1222	1224	to	to	TO	I-VP
O	1225	1227	be	be	VB	I-VP
O	1228	1243	neuroprotective	neuroprotective	JJ	B-ADJP
O	1244	1250	across	across	IN	B-PP
O	1251	1258	several	several	JJ	B-NP
O	1259	1271	experimental	experimental	JJ	I-NP
O	1272	1281	paradigms	paradigm	NNS	I-NP
O	1281	1282	,	,	,	O
O	1283	1286	and	and	CC	O
O	1287	1292	hence	hence	RB	B-VP
O	1293	1298	could	could	MD	I-VP
O	1299	1310	potentially	potentially	RB	I-VP
O	1311	1318	protect	protect	VB	I-VP
O	1319	1329	vulnerable	vulnerable	JJ	B-NP
B-Cell	1330	1335	cells	cell	NNS	I-NP
O	1336	1340	from	from	IN	B-PP
O	1341	1347	damage	damage	NN	B-NP
O	1348	1358	associated	associate	VBN	B-VP
O	1359	1363	with	with	IN	B-PP
O	1364	1372	seizures	seizure	NNS	B-NP
O	1372	1373	.	.	.	O

O	1374	1383	Therefore	Therefore	RB	B-ADVP
O	1383	1384	,	,	,	O
O	1385	1388	the	the	DT	B-NP
O	1389	1393	role	role	NN	I-NP
O	1394	1396	of	of	IN	B-PP
O	1397	1401	VEGF	VEGF	NN	B-NP
O	1402	1407	after	after	IN	B-SBAR
O	1408	1416	seizures	seizure	NNS	B-NP
O	1417	1422	could	could	MD	B-VP
O	1423	1425	be	be	VB	I-VP
O	1426	1432	either	either	CC	O
O	1433	1443	protective	protective	JJ	B-ADJP
O	1444	1446	or	or	CC	I-ADJP
O	1447	1458	destructive	destructive	JJ	I-ADJP
O	1458	1459	.	.	.	O

O	1460	1468	Although	Although	IN	B-SBAR
O	1469	1473	only	only	RB	B-NP
O	1474	1481	further	far	JJR	I-NP
O	1482	1490	research	research	NN	I-NP
O	1491	1495	will	will	MD	B-VP
O	1496	1505	determine	determine	VB	I-VP
O	1506	1509	the	the	DT	B-NP
O	1510	1515	exact	exact	JJ	I-NP
O	1516	1522	nature	nature	NN	I-NP
O	1523	1525	of	of	IN	B-PP
O	1526	1530	VEGF	VEGF	NN	B-NP
O	1530	1531	'	'	POS	B-NP
O	1531	1532	s	s	NN	I-NP
O	1533	1537	role	role	NN	I-NP
O	1538	1543	after	after	IN	B-PP
O	1544	1552	seizures	seizure	NNS	B-NP
O	1552	1553	,	,	,	O
O	1554	1565	preliminary	preliminary	JJ	B-NP
O	1566	1570	data	datum	NNS	I-NP
O	1571	1579	indicate	indicate	VBP	B-VP
O	1580	1584	that	that	IN	B-SBAR
O	1585	1589	VEGF	VEGF	NN	B-NP
O	1590	1595	plays	play	VBZ	B-VP
O	1596	1597	a	a	DT	B-NP
O	1598	1608	protective	protective	JJ	I-NP
O	1609	1613	role	role	NN	I-NP
O	1614	1619	after	after	IN	B-PP
O	1620	1628	seizures	seizure	NNS	B-NP
O	1628	1629	.	.	.	O

